Open Label Immunotherapy of Myoma
NCT03550703
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Myoma;Uterus
Fibroid Uterus
Leiomyoma
Fibroma
Interventions
BIOLOGICAL:
V3-Myoma
Sponsor
Immunitor LLC